Feed FCUV
Summary
35 / 100 · Bulios Score
Valuation 100Growth 0Profitability 20Quality 0Debt 52Stability 44
What speaks for it
- It bought back its own shares for $494.4K in the last fiscal year, 20% of its market value.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 10% a year over the last 3 years.
- It missed profit estimates 5 times in the last 8 quarters.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
2021202220232024202520262027
Diluted EPS (USD)
2021202220232024202520262027
- Analyst estimate
Revenue fell by 31% a year over 5 years. Over the last 3 years it fell by 10% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $4.80M.
Profitability in detailIs it financially healthy?
Debt is a burdenCash and short-term investments $1.60M
Debt $11.1M
Free cash flow over 12 months -$11.2M
Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2023By product
- Revenue 94%
- Revenue Related Party 6.2%
By region
The company reports no revenue by region.
Revenue brings in 94% of revenue. Revenue Related Party grew fastest, by 50% a year.
Segments in detail